Cantor Fitzgerald Starts Stryker (SYK) at Hold; M&A Strategy Strong, But Waiting For Better Entry

Cantor Fitzgerald initiates coverage on Stryker (NYSE: SYK) with a Hold. PT $56.00.

Analyst, Jeremy Feffer, said, "Through an aggressive M&A strategy in which the company has spent roughly $3 billion on acquisitions in the last three years, Stryker has adeptly diversified its product portfolio away from an orthopedic industry hampered in recent years by both cyclical and secular headwinds. The stock's 10% YTD gain has come entirely via multiple expansion, suggesting that Stryker's expected growth this year is already reflected in shares. We would therefore wait for a better entry point."

For an analyst ratings summary and ratings history on Stryker click here. For more ratings news on Stryker click here.

Shares of Stryker closed at $54.57 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Wolfe Research Downgrades Stryker (SYK) to Peerperform
• Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)
• Raymond James Starts SpyGlass Pharma (SGP) at Outperform